Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BVA publishes policy position on gene editing
“Whilst recent work has shown its potential benefits, there remain lots of unknowns and more research is needed” – Elizabeth Mullineaux.
Animal health and welfare must come first, position states.

The British Veterinary Association (BVA) has called for gene editing to only be used on animals when it has a demonstrable health or welfare benefit for them.

The stance has been set out in the BVA’s new policy position, Gene Editing of Animals, which has been published in response to the Genetic Technology (Precision Breeding) Act.

The legislation, passed by Parliament last year, allows for gene editing that does not introduce DNA from another organism to be used on plants and animals in commercial agriculture in England. Any DNA changes must theoretically have been able to occur through selective breeding.

Whilst the BVA’s policy position acknowledges that the technology has potential benefits, including improving resistance to disease, it argues that gene editing should not be used as a way to compensate for reduced welfare standards or poor management.

The position also argues that the regulatory framework around gene editing needs to ensure that it is not used to change the appearance of animal for cosmetic reasons or to improve the competitiveness of an animal used in sport.

Elizabeth Mullineaux, BVA president, said: “Gene editing has the potential to be a powerful tool for improving and protecting animal health and welfare.

“However, it must be used responsibly, never for aesthetic reasons or to boost performance in sport. The welfare of any animals involved must also never be compromised.

“Whilst recent work has shown its potential benefits, there remain lots of unknowns and more research is needed. BVA will work closely with the government to help shape this new legislation to ensure that animal health and welfare remains a top priority.”

A talk on gene editing will be held at this year’s BVA Congress on 15 November at 9.30am in the BVA Congress Theatre. The panellists will be Dominic Wells, professor of translational medicine at the Royal Veterinary College, Penny Hawkins, head of the RSPCA’s Animals in Science Department, and Huw Jones, an independent consultant in agri-innovation and animal bioscience.

The full policy position can be read here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
BSAVA publishes fifth Manual of Canine and Feline Neurology

The BSAVA has published the fifth edition of its BSAVA Manual of Canine and Feline Neurology.

The new edition has been reviewed and updated, including new developments in diagnostics, therapeutic approaches and clinical decision-making. It is structured to support clinicians through diagnosis, treatment and long-term management.

The guide features five new chapters covering acute myelopathies, chronic myelopathies, emergency protocols, neurotoxicology and neuro-oncology.

It also includes over 100 videos, including demonstrations of neurological examinations, clinical presentations and diagnostic procedures.

Nicola Lloyd, publishing manager, said: "Whether you're a general practitioner seeking practical guidance, or a specialist aiming to refine your expertise, this edition remains an indispensable reference for anyone involved in the care of neurologically compromised dogs and cats."